Literature DB >> 18702754

A controlled comparison between single doses of intravenous and intramuscular morphine with respect to analgesic effects and patient safety.

T Tveita1, J Thoner, P Klepstad, O Dale, A Jystad, P C Borchgrevink.   

Abstract

UNLABELLED: BACKGROUND AND AIM OF INVESTIGATION: Intramuscular (IM) administration has been considered to be safer than intravenous (IV) for opioids on wards, but a comparative knowledge of patient safety and analgesic potency following a single dose of IV and IM administration is lacking. This study was carried out to compare patient safety and analgesic efficacy of a single and high dose of morphine given IM or IV for post-operative pain management.
MATERIALS AND METHODS: Thirty-eight patients with post-operative pain following hip replacement surgery were given IM or IV morphine 10 mg at a specified pain level. The study was randomized and double blinded. Time to onset of analgesic effect (11-point numeric rating scale), respiratory function (p(a)CO2, p(a)O2, and respiratory rate), level of sedation (5-point verbal rating scale), and hemodynamic function were recorded.
RESULTS: In the IV group there was a slight but significant increase in p(a)CO2 after 5, 10, and 15 min compared with the IM group (5.2 vs. 4.8, 5.4, vs. 5.0 and 5.5 vs. 5.1 kPa, respectively). The IV group had a significantly faster onset of analgesic effect than the IM group (5 vs. 20 min). Between 5 and 25 min after morphine administration, pain status in the IV group was significantly improved compared with the IM group. Patients in the IV group were slightly more sedated than the IM group 5 and 10 min after morphine.
CONCLUSION: A 10 mg bolus dose of IV morphine given to patients with moderate pain after surgery does not cause severe respiratory depression, but provides more rapid and better initial analgesia than 10 mg given IM. IV morphine even at a dose as high as 10 mg IV is well tolerated if there is a certain level of pain at its administration. The safety of IV morphine on the general ward needs to be further explored in adequately controlled studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18702754     DOI: 10.1111/j.1399-6576.2008.01608.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  7 in total

1.  A Comparative Efficacy of Propacetamol and Ketorolac in Postoperative Patient Controlled Analgesia.

Authors:  Bong Ha Heo; Ji Hun Park; Jung Il Choi; Woong Mo Kim; Hyoung Gon Lee; Soo Young Cho; Myoung Ha Yoon
Journal:  Korean J Pain       Date:  2015-07-01

Review 2.  The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection.

Authors:  Jing-Fen Jin; Ling-Ling Zhu; Meng Chen; Hui-Min Xu; Hua-Fen Wang; Xiu-Qin Feng; Xiu-Ping Zhu; Quan Zhou
Journal:  Patient Prefer Adherence       Date:  2015-07-02       Impact factor: 2.711

3.  An Open-Label Study of Sufentanil Sublingual Tablet 30 Mcg in Patients with Postoperative Pain.

Authors:  Jacob L Hutchins; David Leiman; Harold S Minkowitz; Maurice Jove; Karen P DiDonato; Pamela P Palmer
Journal:  Pain Med       Date:  2018-10-01       Impact factor: 3.750

Review 4.  The role of inhaled methoxyflurane in acute pain management.

Authors:  Keith M Porter; Anthony D Dayan; Sara Dickerson; Paul M Middleton
Journal:  Open Access Emerg Med       Date:  2018-10-18

5.  Intranasal sufentanil versus intravenous morphine for acute severe trauma pain: A double-blind randomized non-inferiority study.

Authors:  Marc Blancher; Maxime Maignan; Cyrielle Clapé; Jean-Louis Quesada; Roselyne Collomb-Muret; François Albasini; François-Xavier Ageron; Stephanie Fey; Audrey Wuyts; Jean-Jacques Banihachemi; Barthelemy Bertrand; Audrey Lehmann; Claire Bollart; Guillaume Debaty; Raphaël Briot; Damien Viglino
Journal:  PLoS Med       Date:  2019-07-16       Impact factor: 11.069

6.  STOP!: a randomised, double-blind, placebo-controlled study of the efficacy and safety of methoxyflurane for the treatment of acute pain.

Authors:  Frank Coffey; John Wright; Stuart Hartshorn; Paul Hunt; Thomas Locker; Kazim Mirza; Patrick Dissmann
Journal:  Emerg Med J       Date:  2014-04-17       Impact factor: 2.740

7.  Methoxyflurane Analgesia in Adult Patients in the Emergency Department: A Subgroup Analysis of a Randomized, Double-blind, Placebo-controlled Study (STOP!).

Authors:  Frank Coffey; Patrick Dissmann; Kazim Mirza; Mark Lomax
Journal:  Adv Ther       Date:  2016-08-27       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.